Lung Cancer

BioAffinity Awarded US Federal Supply Schedule Contract for Noninvasive Lung Test

BioAffinity Technologies’ noninvasive lung cancer test is available to Veterans and military personnel for early-stage lung cancer detection.

Lung Cancer

PROphet Platform’s Predictive Ability to be Demonstrated

OncoHost will highlight the PROphet platform's capability to predict benefits from therapies across various cancers.

Lung Cancer

New ChromaCode Collaboration to Improve NSCLC Biomarker Testing Access

ChromaCode will collaborate with Tennessee Oncology to test the performance of ChromaCode's HDPCR NSCLC biomarker assay.

Personalis’ MRD Assay Detects ctDNA in Lung Cancer Patients Earlier

Oct 23, 2023 | Lung Cancer, Molecular Diagnostics

NeXT Personal ctDNA assay shown to be more sensitive and predictive of clinical outcomes in early-stage lung cancer patients

Thermo Fisher and Boehringer Ingelheim Sign CDx Agreement to Select NSCLC Patients for Targeted Therapy

Oct 19, 2023 | Lung Cancer

Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients.

DELFI Diagnostics Unveils Blood Test for Enhanced Lung Cancer Screening

Oct 10, 2023 | Lung Cancer

DELFI’s blood test provides results by determining the likelihood of detecting lung cancer through low-dose CT, with an NPV of 99.7 percent.

Blood Tests Identify NSCLC Patients Who May Benefit from Immunotherapies

Oct 9, 2023 | Lung Cancer

Liquid biopsies may identify NSCLC patients undergoing immunotherapy who could benefit from treatment with additional drugs.

Liquid Biopsy May Identify NSCLC Patients Who Will Benefit from Radiation

Oct 2, 2023 | Lung Cancer

A novel liquid biopsy test may determine which patients with NSCLC that has spread beyond the lungs will benefit from high-dose radiation.

Why Long-Term Smokers May Have a Disease that Defies Diagnosis

Aug 9, 2023 | Lung Cancer

Millions of Americans with tobacco-related lung disease have symptoms that do not fit any existing tobacco-related disease criteria.

Lung Cancer Mortality Risk Predicted by Blood Test

Jun 30, 2023 | Lung Cancer

A blood-based test developed by researchers can predict the risk of dying from lung cancer when combined with a personalized risk model.

Breath Biopsy Test for Lung Cancer in Development

Jun 23, 2023 | Lung Cancer

Owlstone Medical announced new data on the development of a breath biopsy screening test for the early detection of lung cancer.

New Lung Cancer Classification Model Shows Promise

May 30, 2023 | Lung Cancer

The first-generation lung cancer classification model based on gene expression data is already available for use within Qlucore Insights.

New Class of Biomarkers Predicts Cancer Patient Treatment Response

May 26, 2023 | Hematology & Serology, Lung Cancer

A new class of blood-based biomarkers could be developed into improved or orthogonal tests for predicting tumor responses to treatment.

PROphet Biomarker Model Results to be Presented

May 25, 2023 | Lung Cancer

OncoHost will give a poster presentation demonstrating the accuracy of its PROphet biomarker model at the upcoming 2023 ASCO Annual Meeting.

Steerable Needle, CT Imaging Enable Definitive Diagnosis of Lung Nodule

May 12, 2023 | Lung Cancer

The first lung nodule biopsy procedure using Serpex’s Compass steerable needle guided by Body Vision Medical’s LungVision CT imaging system was used to successfully diagnose a small peripheral nodule in the right lower lobe of the patient’s lung.